Cargando…
Phenotypic switching to hypereosinophilia during cytoreductive therapy for transient abnormal myelopoiesis associated with Down syndrome
Autores principales: | Kobayashi, Kenichiro, Watanabe, Asami, Mizuta, Shumpei, Nishida, Yoshinobu, Heike, Toshio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175812/ https://www.ncbi.nlm.nih.gov/pubmed/35846025 http://dx.doi.org/10.1002/jha2.385 |
Ejemplares similares
-
Down syndrome‐associated transient abnormal myelopoiesis with placental involvement
por: Daneshbod, Yahya, et al.
Publicado: (2022) -
Transient Abnormal Myelopoiesis and AML in Down Syndrome: an Update
por: Bhatnagar, Neha, et al.
Publicado: (2016) -
Predictive factors for the development of leukemia in patients with transient abnormal myelopoiesis and Down syndrome
por: Yamato, Genki, et al.
Publicado: (2021) -
Hypereosinophilia with a pinch of salt and pepper
por: Vitucci, Angelantonio, et al.
Publicado: (2021) -
‘Harlequin cells’ in lymphocyte‐variant hypereosinophilia
por: Vahedi, Amirali, et al.
Publicado: (2022)